Carolyn S.P. Lam
Brigham and Women's Hospital(US)University Medical Center Groningen(NL)Harvard University(US)Chulalongkorn University(TH)University of California, Los Angeles(US)National University of Singapore(SG)University of Groningen(NL)The University of Western Australia(AU)National University Heart Centre Singapore(SG)Baim Institute for Clinical Research(US)Université Bourgogne Franche-Comté(FR)Equilibrium Research(GB)Duke-NUS Medical School(SG)National Heart Centre Singapore(SG)University of Glasgow(GB)University of Birmingham(GB)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Diabetes Treatment and Management, Cardiac pacing and defibrillation studies, Cardiac Imaging and Diagnostics
Most-Cited Works
- → 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure(2021)12,270 cited
- → Empagliflozin in Heart Failure with a Preserved Ejection Fraction(2021)4,371 cited
- → Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction(2022)2,473 cited
- → The Global Health and Economic Burden of Hospitalizations for Heart Failure(2014)1,998 cited
- → 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure(2023)1,935 cited
- → How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)(2019)1,712 cited